𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Successful treatment of acute Budd-Chiari syndrome with percutaneous transluminal angioplasty

✍ Scribed by Y. Shirai; H. Yoshiji; M. Fujimoto; H. Kojima; K. Yanase; T. Namisaki; M. Kitade; K. Yamamoto; H. Sakaguchi; K. Kichikawa; H. Fukui


Publisher
Springer
Year
2004
Tongue
English
Weight
219 KB
Volume
29
Category
Article
ISSN
0942-8925

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Coronary artery aneurysm formation follo
✍ Walford, Gary D. ;Midei, Mark G. ;Aversano, Thomas R. ;Gottlieb, Sidney O. ;Chew πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 598 KB

Restenosis following coronary angioplasty can usually be treated effectively and safely by repeated angioplasty. However, the presence of a complex lesion morphology may bias the clinician away from angioplasty toward either recommending bypass surgery or continuing medical therapy alone in spite of

Possible association between Budd-Chiari
✍ MevlΓΌt Kurt; Ali Shorbagi; Kadri Altundag; Tamer Elkiran; Ibrahim GΓΌllΓΌ; Emin Ka πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 2 views

## Abstract Gemtuzumab ozogamicin (GO; CMA‐676; Mylotargβ„’) is a chemotherapeutic agent approved for the treatment of CD33‐positive acute myelogenous leukemia in patients of age 60 years or older after first relapse. Hepatic veno‐occlusive disease has been reported to develop as a late complication